TCE出海到ADC临床, 中国药企如何破局同质化? 德琪、中国生物制药、百利 26.8亿三箭齐发!

商图药讯
Mar 05

来源:小白学药公众号从TCE出海到ADC临床, 中国药企如何破局同质化? 德琪、中国生物制药、百利 26.8亿三箭齐发!单日 26.8 亿美元!中国创新药 BD 大爆发:TCE 出海 + ADC 获批,3 笔重磅交易改写全球格局2026 年 3 月 4 日,中国创新药行业迎来 “超级 BD 日”—— 单日之内,德琪医药 11.8 亿美元 TCE 出海、中国生物制药 15 亿美元移植领域授权、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10